Table 2.

Survival Model

Factor Effect on Survival P Value
Age  Worse with increasing age  <.001  
Platelets  Survival improves as pretreatment platelet count increases from less than 5,000 to approximately 140,000, then worsens with further increase in platelets <.001  
Treated in PE  Favorable  <.001  
PS 3, 4 Unfavorable  <.001  
Treated as  emergency Unfavorable  .030  
−5/−7*, Unfavorable  <.001 
Other poor  cytogenetics Unfavorable  .050 
Factor Effect on Survival P Value
Age  Worse with increasing age  <.001  
Platelets  Survival improves as pretreatment platelet count increases from less than 5,000 to approximately 140,000, then worsens with further increase in platelets <.001  
Treated in PE  Favorable  <.001  
PS 3, 4 Unfavorable  <.001  
Treated as  emergency Unfavorable  .030  
−5/−7*, Unfavorable  <.001 
Other poor  cytogenetics Unfavorable  .050 
*

Versus a normal karyotype or insufficient material for cytogenetic analysis.

−5/−7 refers to patients with clonal abnormalities involving −5, −7, del 5q−, or del 7q.

Other poor cytogenetics includes all cytogenetic abnormalities associated with AML/MDS, excluding inv(16), t(8;21), and −5/−7.

or Create an Account

Close Modal
Close Modal